Keyphrases
Preeclampsia
100%
Forkhead Box M1 (FOXM1)
100%
Breast Cancer
64%
Epirubicin
50%
Extracellular Vesicles
45%
Gestational Diabetes Mellitus
42%
During Pregnancy
36%
Placenta
34%
Gestational Diabetes
31%
Paclitaxel
30%
Epirubicin Resistance
29%
Trophoblast Invasion
27%
Non-coding RNA (ncRNA)
26%
Selective Intrauterine Growth Restriction (sIUGR)
26%
Forkhead Box O3 (FOXO3)
25%
Trophoblast Migration
25%
Mitotic Catastrophe
25%
Endometrial Stem Cells
25%
History of Preeclampsia
25%
Paclitaxel Resistance
25%
Pregnant Women
24%
Breast Cancer Cells
19%
Spontaneous Preterm Birth (sPTB)
18%
MCF-7
18%
Pregnancy Trimester
18%
Phosphorylation
17%
Patients at Risk
17%
First Trimester
16%
E2F Transcription Factor 1 (E2F1)
16%
Maternal Plasma
16%
Chilean
15%
M1 Protein
15%
Fetus
15%
Doxorubicin
14%
Menstrual Blood
14%
MicroRNA
14%
Angiogenesis
14%
Early Pregnancy
14%
Trophoblast
13%
Placental Ischemia
13%
DNA Damage
13%
Poor Survival
13%
Induced Senescence
13%
Chemoresistance
13%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
13%
DNA Damage Repair
13%
Forkhead Box O1 (FOXO1)
13%
Transcription Factor
13%
Mesenchymal Stem Cells
13%
MCF-7 Cells
13%
Medicine and Dentistry
Pre-Eclampsia
100%
Gestational Diabetes
56%
First Trimester Pregnancy
53%
Trophoblast
52%
Intrauterine Growth Retardation
25%
Placenta
23%
Disease
20%
Messenger RNA
20%
Spontaneous Abortion
18%
Pregnancy
15%
Gestational Age
15%
Angiogenesis
14%
Drug Resistance
14%
Hypoxia
13%
Ischemia
13%
Mesenchymal Stem Cell
13%
Uterine Artery
12%
Neonatal Infant
12%
Paclitaxel
12%
Nidation
12%
Ovarian Cancer
12%
Transcription Factor NFAT
12%
Menstrual Cycle
12%
Menstruation
12%
Long Untranslated RNA
12%
Gingivitis
12%
Tumor Suppressor Gene
12%
Maternal Plasma
12%
Periodontitis
12%
Diagnostic Performance
12%
Pulsatility Index
12%
Maternal Risk Factor
12%
microRNA
12%
Stem Cell
12%
Tissue Plasminogen Activator
12%
Transcription Factors
12%
Uterine Cancer
12%
Aromatase
12%
Breast Cancer
12%
Biological Marker
11%
Placenta Development
10%
Cancer Cell
9%
Small Interfering RNA
9%
Nulliparous
9%
In Vitro
8%
Doxorubicin
8%
Human Umbilical Vein Endothelial Cell
8%
Protein P53
8%
Second Trimester Pregnancy
8%
Progeny
8%
Biochemistry, Genetics and Molecular Biology
Epirubicin
62%
FOXM1
50%
Trophoblast
40%
First Trimester Pregnancy
34%
Cancer Cell
29%
Doxorubicin
25%
Messenger RNA
22%
Blood Plasma
20%
DNA Repair
19%
Promoter Region
18%
Maternal Stress
18%
Stem Cell
17%
Pregnancy
16%
Forkhead Box Protein M1
16%
E2F1
15%
Second Trimester Pregnancy
14%
Angiogenesis
14%
Small Interfering RNA
14%
P38 Mitogen-Activated Protein Kinases
14%
DNA Damage
13%
Prenatal Growth
13%
E2F
12%
Nidation
12%
P53
12%
SIRT6
12%
Mitotic Catastrophe
12%
BRIP1
12%
Birth Weight
12%
Induced Stem Cells
12%
Cisplatin
12%
Long Non-Coding RNA
12%
Small Extracellular Vesicles
12%
Transcription Factor NFAT
12%
BRCA1
12%
FOXA1
12%
Methylation
12%
Tissue Plasminogen Activator
12%
Placenta Development
10%
Third Trimester Pregnancy
8%
Drug Resistance
7%
Progeny
7%
Cell Proliferation
7%
Oxygen Tension
7%
Fibroblast
6%
Carcinogenesis
6%
Low Birth Weight
6%
Population Research
6%
Leptin
6%
Adiponectin
6%
Maternal Age
6%